Pfizer Inc
(PFE)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2023 | 12-2022 | 09-2022 | 06-2022 | 03-2022 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 5,556,000 | 31,407,000 | 26,404,000 | 17,781,000 | 7,870,000 |
| Depreciation Amortization | 1,487,000 | 5,064,000 | 3,545,000 | 2,362,000 | 1,187,000 |
| Income taxes - deferred | -598,000 | -3,764,000 | -3,399,000 | -3,461,000 | -2,321,000 |
| Accounts receivable | N/A | 261,000 | N/A | N/A | N/A |
| Other Working Capital | -5,507,000 | -5,639,000 | -8,081,000 | -3,496,000 | -730,000 |
| Other Operating Activity | 274,000 | 1,938,000 | 2,216,000 | 1,525,000 | 535,000 |
| Operating Cash Flow | $1,212,000 | $29,267,000 | $20,685,000 | $14,711,000 | $6,541,000 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 4,400,000 | 7,954,000 | -5,491,000 | -1,939,000 | 8,072,000 |
| PPE Investments | -1,139,000 | -3,236,000 | -2,235,000 | -1,394,000 | -643,000 |
| Net Acquisitions | N/A | -22,997,000 | -6,225,000 | -6,225,000 | -6,225,000 |
| Purchase Of Investment | -51,000 | -1,913,000 | -1,627,000 | -1,324,000 | -676,000 |
| Sale Of Investment | 124,000 | 641,000 | 446,000 | 226,000 | 52,000 |
| Other Investing Activity | -19,000 | 3,768,000 | 3,759,000 | -90,000 | -13,000 |
| Investing Cash Flow | $3,315,000 | $-15,783,000 | $-11,373,000 | $-10,746,000 | $567,000 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | 237,000 | 3,669,000 | 4,757,000 | 4,391,000 | -220,000 |
| Debt Repayment | -269,000 | -3,298,000 | -1,609,000 | -1,609,000 | -1,609,000 |
| Common Stock Repurchased | N/A | -2,000,000 | -2,000,000 | -2,000,000 | -2,000,000 |
| Dividend Paid | -2,303,000 | -8,983,000 | -6,738,000 | -4,493,000 | -2,249,000 |
| Other Financing Activity | -436,000 | -4,222,000 | -4,229,000 | -347,000 | -500,000 |
| Financing Cash Flow | $-2,771,000 | $-14,834,000 | $-9,819,000 | $-4,058,000 | $-6,578,000 |
| Exchange Rate Effect | -2,000 | -165,000 | -139,000 | -67,000 | -1,000 |
| Beginning Cash Position | 468,000 | 1,983,000 | 1,983,000 | 1,983,000 | 1,983,000 |
| End Cash Position | 2,222,000 | 468,000 | 1,338,000 | 1,824,000 | 2,513,000 |
| Net Cash Flow | $1,754,000 | $-1,515,000 | $-646,000 | $-159,000 | $529,000 |
| Free Cash Flow | |||||
| Operating Cash Flow | 1,212,000 | 29,267,000 | 20,685,000 | 14,711,000 | 6,541,000 |
| Capital Expenditure | -1,139,000 | -3,236,000 | -2,235,000 | -1,394,000 | -643,000 |
| Free Cash Flow | 73,000 | 26,031,000 | 18,450,000 | 13,317,000 | 5,898,000 |